Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Facilities Gain ISO Certification

NEW YORK (GenomeWeb) – Sigma-Aldrich today said that two of its St. Louis facilities have received ISO 13485 certification for expanded quality assurance capabilities. 

The certification extends the firm's ability to manufacture and offer raw materials including proteins, enzymes, and antibodies used in diagnostic assays, Sigma-Aldrich said. With the certification, its in vitro diagnostic customers can also be assured that their supply chain needs will be met, the firm said. 

Sigma-Aldrich's Dekalb site manufactures proteins and enzymes and received ISO 13485 certification after an investment into its production and packaging capabilities, as well as personnel training. Meanwhile, its facility in Barton can now serve as a central North American distribution center for the company's raw materials designed for IVD manufacturing applications. 

Sigma-Aldrich is in the process of being acquired by Merck KGaA for $17 billion. The firms have said that they aim to close the deal by mid-2015.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.